Morning Headlines 5/16/22
PatientIQ, a patient outcomes data and insights vendor, raises $20 million in a Series B funding round.
Amwell Announces Results for First Quarter 2022
Amwell announces Q1 results: revenue up 11%, EPS –$0.26 versus –$0.16, missing analyst expectations for both.
A randomized clinical trial finds that remote monitoring and financial incentives had no impact on readmissions or deaths among discharged heart failure patients.
I use a wiki and was exploring some of the extended character sets. I was startled to learn that the…